Big pharma will definitely pay more for RAC to have this in place as they will continue their research in the US when they buy us out and now they can benefit from what the FDA has granted us.
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene, page-26
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.020(1.27%) |
Mkt cap ! $270.9M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.62 | $1.57 | $151.2K | 95.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20323 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 200 | 1 |
View Market Depth
| Last trade - 13.02pm 16/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |